Business of Biosimilars & Generic Drugs Session Spotlight: Think Different—Navigating the Brave New Globalized Life Science Industry

Steve Burrill is one of the most influential and trusted experts and advocates in the biotech industry, bringing over 40 years of experience with him. He has helped establish and grow many companies and stewarded the development of major strategic partnerships. This year at Business of Biosimilars & Generic Drugs, talk he will be discussing the new paradigm of organizational partnerships required for biosimilar development, approval, and commercialization, as well as how the industry must respond to regulatory change in order to grow.

For more information on Steve's presentation and the rest of  the 13th Annual Business of Biosimilars & Generic Drugs taking place September 12-14, 2012 in Boston, MA, download the agenda here.  As a reader of this blog, when you register to join us and mention code XP1786BLOG, you'll receive a discount of 25% off the standard rate.

Featured Session: Think Different—Navigating the Brave New Globalized Life Science Industry
Featured Speaker: G. Steven Burrill, CEO, BURRILL & COMPANY
About the session: G. Steven Burrill is one of the biotech industry’s greatest icons and advocates, with over 40 years of experience in guiding biotech firms towards greater growth, adaptability, and success. Now in the face of dramatic new regulatory changes and a shaky global economy, Mr. Burrill will help you focus on the key factors now impacting follow-on biologics and guide your company towards long-term staying power.

• • Strategic partnerships and acquisitions for biosimilar development: how big is this trend, and how can you take advantage if you aren’t already?
• • Healthcare reform in an election year: make sure that whoever loses in November, you win
• • Outlook and options for reimbursement amid economic uncertainty and global competition

Share this article with your social network, just click below to share now!

Share |

Create a compelling and successful marketing strategy for your follow-on biopharmaceuticals

We are pleased to invite you to attend the 13th annual Business of Biosimilars and Generic Drugs – the only conference in the United States devoted entirely to building and executing a reliable market-entry and commercialization strategy for your follow-on biopharmaceuticals.

Our expert faculty will provide you with senior executive-level expert insight on all of your critical success factors:

• - An up-to-date toolkit for regulatory submission packages that will guarantee timely approval, including the latest insights on the FDA’s draft guidelines for biosimilars
• - Success strategies from industry leaders on how to overcome IP challenges and guarantee product availability
• - An unequaled spectrum of international case studies offering lessons on the commercialization of biosimilars and generic drugs in North and South America, Western and Eastern Europe, North Africa, the Middle East, and the Far East

And in an unprecedented step that will help provide a clear path towards reimbursement of the newer product class, this year we have multiple discussions aimed at specifically translating into a biosimilars context the market success strategies employed by generic drugs.

Featured Session on FDA Regulatory Updates:

• - Outlook and Strategic Impact of U.S. Biosimilar Approval Pathway from Pfizer and Shire
• - Regulatory Extrapolation of Therapeutic Indications for Complex Biosimilars: Clinical and Regulatory Updates, and Ways to Proceed from Takeda Pharmaceuticals

Featured Session on Strategic Partnerships:

• - Think Different: Navigating the Brave New Globalized Life Sciences Industry presented by G. Steven Burrill, CEO, BURRILL & COMPANY

Featured Session on Learning The Right Market Lessons from Generic Drugs:

• - Reimbursement Strategies for Generics & Biosimilars Around the World presented by Express Scripts and Bristol Myers Squibb

For more information on these presentation and the rest of the program, download the brochure here.

The 13th Annual Business of Biosimilars and Generic Drugs will take place September 10-12, 2012 in Boston, MA. As a reader of this blog, you receive an exclusive discount of 25% off of the standard price when you register to join us and use priority code XP1786BLOG. Have any questions about the event? Feel free to email Jennifer Pereira. or visit the webpage: http://bit.ly/Ja99wS

Share this article with your social network, just click below to share now!

Share |